These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 37154158)

  • 1. Persistent hepatic IFN system activation in HBV-HDV infection determines viral replication dynamics and therapeutic response.
    Chida T; Ishida Y; Morioka S; Sugahara G; Han C; Lam B; Yamasaki C; Sugahara R; Li M; Tanaka Y; Liang TJ; Tateno C; Saito T
    JCI Insight; 2023 May; 8(9):. PubMed ID: 37154158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDV RNA replication is associated with HBV repression and interferon-stimulated genes induction in super-infected hepatocytes.
    Alfaiate D; Lucifora J; Abeywickrama-Samarakoon N; Michelet M; Testoni B; Cortay JC; Sureau C; Zoulim F; Dény P; Durantel D
    Antiviral Res; 2016 Dec; 136():19-31. PubMed ID: 27771387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction.
    Suárez-Amarán L; Usai C; Di Scala M; Godoy C; Ni Y; Hommel M; Palomo L; Segura V; Olagüe C; Vales A; Ruiz-Ripa A; Buti M; Salido E; Prieto J; Urban S; Rodríguez-Frias F; Aldabe R; González-Aseguinolaza G
    J Hepatol; 2017 Oct; 67(4):669-679. PubMed ID: 28527664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis D virus replication is sensed by MDA5 and induces IFN-β/λ responses in hepatocytes.
    Zhang Z; Filzmayer C; Ni Y; Sültmann H; Mutz P; Hiet MS; Vondran FWR; Bartenschlager R; Urban S
    J Hepatol; 2018 Jul; 69(1):25-35. PubMed ID: 29524530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation.
    Lütgehetmann M; Mancke LV; Volz T; Helbig M; Allweiss L; Bornscheuer T; Pollok JM; Lohse AW; Petersen J; Urban S; Dandri M
    Hepatology; 2012 Mar; 55(3):685-94. PubMed ID: 22031488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse models of hepatitis B and delta virus infection.
    Dandri M; Lütgehetmann M
    J Immunol Methods; 2014 Aug; 410():39-49. PubMed ID: 24631647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis D virus-induced interferon response and administered interferons control cell division-mediated virus spread.
    Zhang Z; Ni Y; Lempp FA; Walter L; Mutz P; Bartenschlager R; Urban S
    J Hepatol; 2022 Oct; 77(4):957-966. PubMed ID: 35636579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights into HDV persistence: The role of interferon response and implications for upcoming novel therapies.
    Zhang Z; Urban S
    J Hepatol; 2021 Mar; 74(3):686-699. PubMed ID: 33276031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of in vivo hepatitis D virus infection.
    Goyal A; Murray JM
    J Theor Biol; 2016 Jun; 398():9-19. PubMed ID: 27012516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis Delta Virus Acts as an Immunogenic Adjuvant in Hepatitis B Virus-Infected Hepatocytes.
    Tham CYL; Kah J; Tan AT; Volz T; Chia A; Giersch K; Ladiges Y; Loglio A; Borghi M; Sureau C; Lampertico P; Lütgehetmann M; Dandri M; Bertoletti A
    Cell Rep Med; 2020 Jul; 1(4):100060. PubMed ID: 33205065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis Delta co-infection in humanized mice leads to pronounced induction of innate immune responses in comparison to HBV mono-infection.
    Giersch K; Allweiss L; Volz T; Helbig M; Bierwolf J; Lohse AW; Pollok JM; Petersen J; Dandri M; Lütgehetmann M
    J Hepatol; 2015 Aug; 63(2):346-53. PubMed ID: 25795587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of mathematical models for the analysis of hepatitis delta virus viral dynamics.
    de Sousa BC; Cunha C
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20862328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of variants in LGP2 on MDA5-mediated activation of interferon response and suppression of hepatitis D virus replication.
    Gillich N; Zhang Z; Binder M; Urban S; Bartenschlager R
    J Hepatol; 2023 Jan; 78(1):78-89. PubMed ID: 36152765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay between Hepatitis D Virus and the Interferon Response.
    Zhang Z; Urban S
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33233762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies to inhibit entry of HBV and HDV into hepatocytes.
    Urban S; Bartenschlager R; Kubitz R; Zoulim F
    Gastroenterology; 2014 Jul; 147(1):48-64. PubMed ID: 24768844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical assessment of antiviral combination therapy in a genetically humanized mouse model for hepatitis delta virus infection.
    Winer BY; Shirvani-Dastgerdi E; Bram Y; Sellau J; Low BE; Johnson H; Huang T; Hrebikova G; Heller B; Sharon Y; Giersch K; Gerges S; Seneca K; Pais MA; Frankel AS; Chiriboga L; Cullen J; Nahass RG; Lutgehetmann M; Toettcher JE; Wiles MV; Schwartz RE; Ploss A
    Sci Transl Med; 2018 Jun; 10(447):. PubMed ID: 29950446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JAK1 promotes HDV replication and is a potential target for antiviral therapy.
    Heuschkel MJ; Bach C; Meiss-Heydmann L; Gerges E; Felli E; Giannone F; Pessaux P; Schuster C; Lucifora J; Baumert TF; Verrier ER
    J Hepatol; 2024 Feb; 80(2):220-231. PubMed ID: 37925078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging anti-HDV drugs and HBV cure strategies with anti-HDV activity.
    Roca Suarez AA; Batbold E; Bartosch B; Dashdorj N; Testoni B; Zoulim F
    Liver Int; 2023 Aug; 43 Suppl 1():87-95. PubMed ID: 37017060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
    Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
    Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleic Acid Polymers Are Active against Hepatitis Delta Virus Infection
    Beilstein F; Blanchet M; Vaillant A; Sureau C
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29212929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.